← Main Index Directory
TB-500 Assay Protocol
In-Vitro ArchitectureDelivery & Half-Life Parameters
Validated Mapping Vector: Subcutaneous or intramuscular injection.
Biological Half-Life Metric: Extended systemic half-life (~72 hours inside tissue structures).
Recommended In-Vitro Dosing Architecture
Requires a loading phase: 5mg to 7.5mg weekly (split into two injections) for 4 weeks. Maintenance phase steps down to 2mg to 2.5mg once weekly.
Standard Target Observation Timelines
Mapped via high-concentration loading phases for 2 to 4 weeks, transitioning into maintenance blocks.